p53 tumor suppressor protein regulates the levels of huntingtin gene expression

被引:81
作者
Feng, Z
Jin, S
Zupnick, A
Hoh, J
de Stanchina, E
Lowe, S
Prives, C
Levine, AJ
机构
[1] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA
[2] Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ USA
[3] Univ Med & Dent New Jersey, Dept Pharmacol, Piscataway, NJ 08854 USA
[4] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
[5] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
[6] Cold Spring Harbor Labs, Cold Spring Harbor, NY USA
[7] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA
关键词
p53; hungtingtin; Huntington's disease; p53-responsive element; transcription regulation; gene expression;
D O I
10.1038/sj.onc.1209021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 protein is a transcription factor that integrates various cellular stress signals. The accumulation of the mutant huntingtin protein with an expanded polyglutamine tract plays a central role in the pathology of human Huntington's disease. We found that the huntingtin gene contains multiple putative p53-responsive elements and p53 binds to these elements both in vivo and in vitro. p53 activation in cultured human cells, either by a temperature-sensitive mutant p53 protein or by gamma-irradiation (gamma-irradiation), increases huntingtin mRNA and protein expression. Similarly, murine huntingtin also contains multiple putative p53-responsive elements and its expression is induced by p53 activation in cultured cells. Moreover, gamma-irradiation, which activates p53, increases huntingtin gene expression in the striatum and cortex of mouse brain, the major pathological sites for Huntington's disease, in p53+/+ but not the isogenic p53 -/- mice. These results demonstrate that p53 protein can regulate huntingtin expression at transcriptional level, and suggest that a p53 stress response could be a modulator of the process of Huntington's disease.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 21 条
[1]   Different phenotypic expression in monozygotic twins with Huntington disease [J].
Anca, MH ;
Gazit, E ;
Loewenthal, R ;
Ostrovsky, O ;
Frydman, M ;
Giladi, N .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 124A (01) :89-91
[2]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[3]   Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain [J].
DiFiglia, M ;
Sapp, E ;
Chase, KO ;
Davies, SW ;
Bates, GP ;
Vonsattel, JP ;
Aronin, N .
SCIENCE, 1997, 277 (5334) :1990-1993
[4]   Mouse Huntington's disease homolog mRNA levels: variation and allele effects [J].
Dixon, KT ;
Cearley, JA ;
Hunter, JM ;
Detloff, PJ .
GENE EXPRESSION-THE JOURNAL OF LIVER RESEARCH, 2003, 11 (5-6) :221-231
[5]   DEFINITION OF A CONSENSUS BINDING-SITE FOR P53 [J].
ELDEIRY, WS ;
KERN, SE ;
PIETENPOL, JA ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE GENETICS, 1992, 1 (01) :45-49
[6]  
Georgiou N, 1999, MOVEMENT DISORD, V14, P320, DOI 10.1002/1531-8257(199903)14:2<320::AID-MDS1018>3.0.CO
[7]  
2-Z
[8]   The p53MH algorithm and its application in detecting p53-responsive genes [J].
Hoh, J ;
Jin, S ;
Parrado, T ;
Edington, J ;
Levine, AJ ;
Ott, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (13) :8467-8472
[9]  
Jin SK, 2001, J CELL SCI, V114, P4139
[10]   MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation [J].
Jin, YT ;
Zeng, SX ;
Dai, MS ;
Yang, XJ ;
Lu, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (34) :30838-30843